Merck Manual

Please confirm that you are not located inside the Russian Federation

honeypot link

Pancreas Transplantation


Martin Hertl

, MD, PhD, Rush University Medical Center

Last full review/revision Jun 2020| Content last modified Jun 2020
Click here for the Professional Version

Pancreas transplantation is the removal of a healthy pancreas from a recently deceased person or rarely a part of a pancreas from a living person and its transfer into person with severe diabetes whose pancreas no longer makes sufficient insulin.

Pancreas transplantation is done for people who have diabetes if their pancreas cannot make enough insulin. More than 80% of people who have diabetes and who receive a pancreas transplant have normal blood sugar levels afterward and no longer need insulin, but they trade this benefit for the need to take immunosuppressants, with the risk of infections and other side effects.

Because injectable insulin is a safe and reasonably effective treatment for diabetes, freedom from insulin is not considered a sufficient reason for pancreas transplantation. Thus, this procedure is usually done only in people with diabetes if:

  • They also have kidney failure.

  • They cannot keep their blood sugar levels within an acceptable range, particularly if they do not sense when their blood sugar levels become too low.

(Occasionally, when blood sugar levels remain too low for too long, organs, including the brain, are permanently damaged.)

Overall, more than 90% of people who receive a pancreas transplant receive a kidney transplant at the same time. Kidney transplantation requires abdominal surgery and the use of immunosuppressants afterward, so transplanting a pancreas at the same time adds few risks.

Pancreas transplantation may be beneficial for people who are taking insulin but still have high blood sugar levels and whose blood sugar levels become dangerously low after taking insulin.

Sometimes only certain cells from the pancreas are transplanted (called pancreatic islet cell transplantation).

More than 95% of people survive at least 1 year after transplantation.


Donors are usually people who have all of the following characteristics:

  • They recently died.

  • They were aged 10 to 55.

  • They had not abused alcohol.

  • They had not had prediabetes (blood glucose levels that are higher than normal but not high enough to be labeled diabetes) or diabetes.

If both a pancreas and kidney are being transplanted, they must come from the same donor.

Parts of a pancreas from a living donor have been used, but this procedure is rarely done because the risks to the donor are high.

Procedure for Pancreas Transplantation

The procedure may involve

  • Transplanting a pancreas and kidney at the same time (simultaneous pancreas-kidney transplantation)

  • Transplanting a kidney first, then a pancreas (pancreas-after-kidney transplantation)

  • Transplanting only a pancreas (pancreas-alone transplantation)

Pancreas transplantation is a major operation, requiring a long incision in the abdomen and a general anesthetic. The recipient’s own pancreas is not removed.

Typically, the operation takes about 3 hours and the hospital stay is 1 to 3 weeks.

Drugs to inhibit the immune system (immunosuppressants), including corticosteroids, are started the day of transplantation. These drugs can help reduce the risk of rejection.

Complications of Pancreas Transplantation

Transplantation can cause various complications.


Despite the use of immunosuppressants, one or more episodes of rejection occurs in 20 to 40% of people after pancreas transplantation (with or without a kidney).

When a pancreas and kidney are transplanted at the same time, the risk of rejection is higher, but rejection tends to occur later and more often than when only a kidney is transplanted. Usually, both organs are rejected. However, treatment of rejection has a high success rate.

NOTE: This is the Consumer Version. DOCTORS: Click here for the Professional Version
Click here for the Professional Version
Others also read

Test your knowledge

Chronic Granulomatous Disease
Chronic granulomatous disease is a hereditary disorder of the immune system. In this disorder, phagocytes, a type of white blood cell, do not function properly. Normal phagocytes ingest and then kill microorganisms invading the body. In chronic granulomatous disease, the phagocytes can ingest invaders but cannot kill them. They lack the ability to produce certain substances that normally enable them to kill. When does chronic granulomatous disease typically first appear?
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID

Also of Interest

Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID
Download the Manuals App iOS ANDROID